drugset / Trial / NCT01325493

Low Dose Ketamine Study on Opioid Tolerance and Hyperalgesia

NCT01325493 ↗

Phase 4 Completed 54 enrolled Julia Finkel
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to: 1\. Establish whether ketamine can decrease opioid consumption and modulate the onset of opioid tolerance and prevent opioid-induced hyperalgesia in pediatric subjects, ages 10 years to 18 years, undergoing posterior spinal fusion and instrumentation.

Timeline

Start
2010-01
Primary completion
2012-05
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule 0.1 mg/kg Intravenous